(Q36198685)

12 August 2017

1 reference

title

Filovirus-like particles as vaccines and discovery tools (English)

1 reference

12 August 2017

4

Sina Bavari

1 reference

12 August 2017

1

Kelly L Warfield

1 reference

12 August 2017

Dana L Swenson

2

1 reference

12 August 2017

Gretchen Demmin

series ordinal

3

1 reference

12 August 2017

language of work or name

1 reference

1 June 2005

1 reference

Expert Review of Vaccines

12 August 2017

published in

1 reference

12 August 2017

volume

4

1 reference

12 August 2017

issue

3

1 reference

12 August 2017

page(s)

429-440

1 reference

Potential mammalian filovirus reservoirs

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Hemorrhagic fever viruses as biological weapons: medical and public health management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Defense against filoviruses used as biological weapons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

The evolving field of biodefence: therapeutic developments and diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Interactions of Marburg virus nucleocapsid proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Biochemical and functional characterization of the Ebola virus VP24 protein: implications for a role in virus assembly and budding

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Contribution of ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Association of ebola virus matrix protein VP40 with microtubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Processing of the Ebola virus glycoprotein by the proprotein convertase furin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Proteolytic processing of Marburg virus glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Ectodomain shedding of the glycoprotein GP of Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Infection and activation of monocytes by Marburg and Ebola viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Pathogenesis of experimental Ebola virus infection in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

An analysis of features of pathogenesis in two animal models of Ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Role of natural killer cells in innate protection against lethal ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Mannosyl glycodendritic structure inhibits DC-SIGN-mediated Ebola virus infection in cis and in trans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Glycosylation and oligomerization of the spike protein of Marburg virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Covalent modifications of the ebola virus glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Persistent infection with ebola virus under conditions of partial immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Marburg virus vaccines: comparing classical and new approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Inactivated Marburg virus elicits a nonprotective immune response in Rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Evaluation in nonhuman primates of vaccines against Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Towards a vaccine against Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Vaccine research efforts for filoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Development of a preventive vaccine for Ebola virus infection in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Vaccine for AIDS and Ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Virus-like particles: a new family of delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Virus-like particles as immunogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Ebola virus: from discovery to vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Analysis of Ebola virus and VLP release using an immunocapture assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Molecular mechanisms of filovirus cellular trafficking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Structures of virus and virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Bacterial carriers and virus-like-particles as antigen delivery devices: role of dendritic cells in antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Ebola virus-like particles protect from lethal Ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Ebola and Marburg virus-like particles activate human myeloid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Depletion of peripheral blood T lymphocytes and NK cells during the course of ebola hemorrhagic Fever in cynomolgus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Nedd4 regulates egress of Ebola virus-like particles from host cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

Ebola virus: the search for vaccines and treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.429

21 January 2018

Identifiers

DOI

10.1586/14760584.4.3.429

1 reference

12 August 2017

1 reference